Uniting Global Forces Against the Silent Pandemic: The Commonwealth Alliance of Medical Professionals on Antimicrobial Resistance
DOI:
https://doi.org/10.47203/IJCH.2026.v38i02.051Keywords:
Antibiotic resistance, Antimicrobial resistance (AMR), Antibiotic, Antimicrobial StewardshipAbstract
Antimicrobial resistance (AMR) poses a critical challenge to modern medicine, fundamentally undermining our ability to treat infectious diseases effectively(1). Antimicrobials, including antibiotics, antivirals, antifungals, and antiparasitics, are essential for preventing and treating infections in humans, animals, and plants. However, pathogens can evolve over time, leading to resistance against these antimicrobials. This natural evolutionary process is drastically accelerated by the overuse and misuse of antimicrobials, rendering conventional treatments ineffective. As a result, infections become increasingly difficult to manage, escalating the risks of disease spread, severe illness, and mortality.
Antimicrobial resistance presents a major threat to global health, contributing to increased mortality and morbidity rates. The World Health Organization (WHO) has declared AMR a "silent pandemic," emphasizing the critical need to tackle this issue(2). AMR poses a worldwide threat, with drug-resistant diseases claiming the lives of 4.95 million individuals in 2019, of which 1.27 million deaths were directly related to AMR(3). AMR adds to significant costs, for both health systems and national economies, posing a problem for all countries at all income levels. AMR creates the need for more expensive and intensive care, and affects the productivity of patients and caregivers through prolonged hospital stays. In response to the urgent need to address the growing burden of AMR, the Commonwealth Medical Association has spearheaded the launch of the Commonwealth Alliance of Medical Professionals on Antimicrobial Resistance (CAMP-AMR). This initiative aims to unite National Medical Associations across the Commonwealth to collaborate on developing and implementing sustainable strategies that tackle the pervasive issue of AMR. By facilitating international cooperation and shared expertise, CAMP-AMR seeks to enhance global and national efforts against AMR. While global initiatives like the Global Action Plan on AMR(4) provide a robust framework, CAMP-AMR offers a Commonwealth-specific mechanism to leverage shared cultural, professional, and structural similarities for targeted interventions.
Downloads
References
Antimicrobial resistance (Internet). (cited 2024 Oct 6). Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
Global antimicrobial resistance forum launched to help tackle common threat to planetary health (Internet). (cited 2024 Jul 29). Available from: https://www.who.int/news-room/articles-detail/global-antimicrobial-resistance-forum-launched-to-help-tackle-common-threat-to-planetary-health
Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022 Feb 12;399(10325):629–55.
Global action plan on antimicrobial resistance (Internet). (cited 2024 Nov 26). Available from: https://www.who.int/publications/i/item/9789241509763
Nations U. UN High-level Meeting on Antimicrobial Resistance (Internet). United Nations. United Nations; (cited 2024 Nov 26). Available from: https://www.un.org/en/civil-society/high-level-meeting-antimicrobial-resistance
4th Global High-Level Ministerial Conference on Antimicrobial Resistance (Internet). (cited 2024 Nov 26). Available from: https://www.who.int/news-room/events/detail/2024/11/14/default-calendar/4th-global-high-level-ministerial-conference-on-antimicrobial-resistance
Indian Medical Association (Internet). (cited 2024 Nov 26). Available from: https://www.ima-india.org/ima/free-way-page.php?pid=2
Downloads
Published
How to Cite
License
Copyright (c) 2026 Venkatesh Karthikeyan

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.